Treatment of invasive candidiasis: between guidelines and daily clinical practice (Q46752133)

24 December 2017

editorial

0 references

title

Treatment of invasive candidiasis: between guidelines and daily clinical practice (English)

1 reference

24 December 2017

1 reference

1 reference

Enrico Tagliaferri

1

1 reference

24 December 2017

Francesco Menichetti

series ordinal

2

1 reference

24 December 2017

publication date

27 March 2015

1 reference

24 December 2017

Expert Review of Anti-infective Therapy

published in

1 reference

24 December 2017

volume

13

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

685-689

1 reference

24 December 2017

Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Epidemiology of Candida species infections in critically ill non-immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Epidemiological trends in nosocomial candidemia in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

(1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Invasive candidiasis: a review of nonculture-based laboratory diagnostic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Anidulafungin versus fluconazole for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Cost-effectiveness of anidulafungin in confirmed candidaemia and other invasive Candida infections in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Pharmacoeconomic evaluation of caspofungin versus liposomal amphotericin B in empirical treatment of invasive fungal infections in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

De-escalation from micafungin is a cost-effective alternative to traditional escalation from fluconazole in the treatment of patients with systemic Candida infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Antifungal stewardship in invasive Candida infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

Arterial blood culture to hasten the diagnosis of candidemia in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.1029916

10.1586/14787210.2015.1029916

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

25818660

1 reference

24 December 2017